Skip to main content

Table 2 Up-to-date antigen wise coverage at 12 months of age in study participants by allocation group

From: Effect of vaccine reminder and tracker bracelets on routine childhood immunization coverage and timeliness in urban Pakistan (2017-18): a randomized controlled trial

  Intervention A: Adapted Alma Sana Bracelet Intervention B: Star Bracelet Control
Total Number of Children, n (%) 482   482   481  
At BCG 217/482 (45.0) 200/482 (41.5) 216/481 (44.9)
At Pentavalent-1 265/482 (55.0) 282/482 (58.5) 265/481 (55.1)
Pentavalent-1* 208/217 (95.8) 183/200 (91.5) 202/216 (93.5)
Pentavalent-2 445/482 (92.3) 434/482 (90.0) 432/481 (89.6)
Pentavalent-3 408/482 (84.6) 411/481 (85.4) 399/481 (83.0)
Measles-1 345/479 (72.0) 339/481 (70.5) 329/480 (68.5)
  1. *For children enrolled at BCG; Bacille Calmette Guérin
  2. ** None of the differences are significant at p ≤ 0.05
  3. For Pentavalent-3 and Measles-1 analysis, we have excluded the children who passed away before they were due for the relevant vaccine